Chemotherapy-related skin toxicity
Chemotherapy-related skin toxicity is a research topic within Dermatology. Science Explorer counts 13k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the dermatological side effects and complications associated with chemotherapy, including extravasation of antineoplastic agents, hand-foot syndrome, radiation recall dermatitis, and nail changes. It also discusses the management and prevention strategies for these chemotherapy-induced dermatological toxicities.
- Chemotherapy
- Dermatological Toxicity
- Extravasation
- Hand-Foot Syndrome
- Radiation Recall
- Pegylated Liposomal Doxorubicin
- Management
- Erythrodysesthesia
- Nail Changes
- Prevention
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 1.3k per year above
- Top-10% rate
- 10.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +25% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Chemotherapy-related skin toxicity research?
By volume, the United States and China publish the most (585 and 190 works in 2022–2025).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Chemotherapy-related skin toxicity research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Chemotherapy-related skin toxicity research, followed by Memorial Sloan Kettering Cancer Center and Philipps University of Marburg.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 11 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 10 works
- 3 Philipps University of MarburgGermany 9 works
- 4 The University of Texas MD Anderson Cancer CenterUnited States 7 works
- 5 University of MiamiUnited States 7 works
- 6 Harvard UniversityUnited States 7 works
- 7 Yale UniversityUnited States 6 works
- 8 Post Graduate Institute of Medical Education and ResearchIndia 6 works
- 9 Mayo Clinic in ArizonaUnited States 6 works
- 10 University of MichiganUnited States 6 works
Where is Chemotherapy-related skin toxicity research done?
The largest centres of Chemotherapy-related skin toxicity research in 2022–2025 are New York (United States), Tokyo (Japan), Beijing (China) and São Paulo (Brazil).
Largest cities, 2022–2025
Where is the best place to study Chemotherapy-related skin toxicity?
Among universities, judged by research, All India Institute of Medical Sciences and Philipps University of Marburg score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia | 40.1 | 1.3% | 8.4× | 11 | +157.4% |
| 2 | Philipps University of MarburgGermany | 33.3 | 0.0% | 16.9× | 9 | -84.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Chemotherapy-related skin toxicity research growing?
Output in 2018–2022 was 25% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Chemotherapy-related skin toxicity.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.